Table 2 For pass evaluation of selected natural compounds using Way2drug server.
Compounds ZINC ID | PubChem Compound ID | Pa | Pi | Activity |
|---|---|---|---|---|
ZINC03847075 | CID2751895 | 0.385 | 0.019 | Cancer associated disorders treatment |
0.261 | 0.056 | Antileukemic | ||
0.262 | 0.057 | Apoptosis antagonist | ||
0.220 | 0.114 | Cytostatic | ||
0.142 | 0.064 | Cancer procoagulant inhibitor | ||
0.158 | 0.095 | Microtubule formation inhibitor | ||
0.106 | 0.049 | Tubulin antagonist | ||
0.180 | 0.144 | Anticarcinogenic | ||
0.058 | 0.025 | Tubulin GTPase inhibitor | ||
ZINC12889138 | CID25579501 | 0.190 | 0.019 | Tubulin antagonist |
0.214 | 0.068 | Prostate cancer treatment | ||
0.246 | 0.168 | Apoptosis agonist | ||
0.045 | 0.029 | Beta tubulin antagonist | ||
0.177 | 0.172 | Apoptosis antagonist | ||
ZINC08952577 | CID16401622 | 0.604 | 0.026 | Apoptosis agonist |
0.352 | 0.053 | Cytostatic | ||
0.314 | 0.053 | Anticarcinogenic | ||
0.236 | 0.029 | Microtubule formation inhibitor | ||
0.262 | 0.056 | Antileukemic | ||
0.180 | 0.088 | Prostate cancer treatment | ||
0.060 | 0.018 | Microtubule stabilization | ||
ZINC08952607 | CID40884666 | 0.423 | 0.018 | Prostate cancer treatment |
0.408 | 0.024 | Antileukemic | ||
0.418 | 0.065 | Apoptosis agonist | ||
0.182 | 0.148 | Cytostatic | ||
0.142 | 0.116 | Microtubule formation inhibitor |
